ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma

J Labrador, M Cabrero-Calvo, E Pérez-López… - Annals of …, 2014 - Springer
The management of relapsed or refractory Hodgkin's lymphoma (RR-HL) remains a
challenge for hematologists and oncologists. Salvage chemotherapy followed by autologous …
被引用次数：51 相关文章

ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma

J Labrador, M Cabrero-Calvo, E Pérez-López… - Annals of …, 2014 - infona.pl
The management of relapsed or refractory Hodgkin's lymphoma (RR-HL) remains a
challenge for hematologists and oncologists. Salvage chemotherapy followed by autologous …

ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma.

J Labrador, M Cabrero-Calvo, E Pérez-López… - Annals of …, 2014 - europepmc.org
The management of relapsed or refractory Hodgkin's lymphoma (RR-HL) remains a
challenge for hematologists and oncologists. Salvage chemotherapy followed by autologous …

ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma

J Labrador, M Cabrero-calvo… - Annals of …, 2014 - search.proquest.com
The management of relapsed or refractory Hodgkin's lymphoma (RR-HL) remains a
challenge for hematologists and oncologists. Salvage chemotherapy followed by autologous …

ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma

J Labrador, M Cabrero-Calvo… - Annals of …, 2014 - mdanderson.elsevierpure.com
The management of relapsed or refractory Hodgkin's lymphoma (RR-HL) remains a
challenge for hematologists and oncologists. Salvage chemotherapy followed by autologous …

ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma.

J Labrador, M Cabrero-Calvo… - Annals of …, 2014 - search.ebscohost.com
The management of relapsed or refractory Hodgkin's lymphoma (RR-HL) remains a
challenge for hematologists and oncologists. Salvage chemotherapy followed by autologous …

ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma

J Labrador, M Cabrero-Calvo… - Annals of …, 2014 - pubmed.ncbi.nlm.nih.gov
The management of relapsed or refractory Hodgkin's lymphoma (RR-HL) remains a
challenge for hematologists and oncologists. Salvage chemotherapy followed by autologous …